Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726233 | SCV000343106 | uncertain significance | not provided | 2017-02-06 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000357364 | SCV000613015 | uncertain significance | not specified | 2017-04-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000536787 | SCV000657378 | likely benign | Bethlem myopathy 1A | 2023-11-17 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000726233 | SCV001714682 | uncertain significance | not provided | 2020-03-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000726233 | SCV001992477 | uncertain significance | not provided | 2020-02-20 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Previously reported as a variant of uncertain significance in an individual with a clinical diagnosis of LGMD (Nallamilli et al., 2018); This variant is associated with the following publications: (PMID: 30564623) |
Revvity Omics, |
RCV000726233 | SCV003834633 | uncertain significance | not provided | 2022-03-09 | criteria provided, single submitter | clinical testing |